- 期刊
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
延伸閱讀
- 黃織芬（2013）。Study of the Molecular in Bone Metastasis of Prostate Cancer and the Clinical Application〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2013.00292
- 李彩緣、陳鈺如、汪奇志、李秋香（2015）。Outcome of Hepatocellular Carcinoma Patients Postoperative Receiving Antiviral Therapy Follow Up- A Case Study。元培學報，(22)，29-35。https://www.airitilibrary.com/Article/Detail?DocID=10287086-201512-201609200004-201609200004-29-35
- Lucas, S. M., & Heath, E. I. (2012). Current Challenges in Development of Differentially Expressed and Prognostic Prostate Cancer Biomarkers. Prostate Cancer, 2012(), 165-173. https://doi.org/10.1155/2012/640968
- Huang, C. A. (2019). The role of methyltransferase MTx in prostate cancer cells progression and resistant to anti-androgen drugs treatment [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201902351
- 李政學（2020）。Association between Hematopoietic Cell CD Marker Gene Polymorphisms and Prostate Cancer Progression〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-0201202022320400